Education
About Us
Working with TipRanks
Follow Us
Lyell Immunopharma (LYEL)
NASDAQ:LYEL
LYEL Analyst Ratings
Hold
1 Buy
0 Hold
1 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
LYEL Stock 12 Month Forecast
Average Price Target
$28.50
▲(19.90% Upside)
| Highest Price Target$45.00 | Average Price Target$28.50 | Lowest Price Target$12.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Bank of America Securities
$12
Sell
-49.52%
Downside
Reiterated
12/09/25
H.C. Wainwright
$20→$45
Buy
89.31%
Upside
Upgraded
12/09/25
Lucid Capital
$20
Buy
-15.86%
Downside
Initiated
09/26/25
Morgan Stanley
Hold
―
Reiterated
06/16/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bank of America Securities
$12
Sell
-49.52%
Downside
Reiterated
12/09/25
H.C. Wainwright
$20→$45
Buy
89.31%
Upside
Upgraded
12/09/25
Lucid Capital
$20
Buy
-15.86%
Downside
Initiated
09/26/25
Morgan Stanley
Hold
―
Reiterated
06/16/25
Best Analysts Covering Lyell Immunopharma
3 Months
xxx
Success Rate
5/7 ratings generated profit
Average Return
-2.93%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of -2.93% per trade.
1 Year
Success Rate
2/7 ratings generated profit
Average Return
-74.56%
reiterated a sell rating last month
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -74.56% per trade.
2 Years
xxx
Success Rate
1/7 ratings generated profit
Average Return
-78.51%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -78.51% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
LYEL Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
1
1
1
1
1
Buy
0
0
0
0
0
Hold
1
1
1
1
1
Sell
1
1
1
1
1
Strong Sell
0
0
0
1
1
total
3
3
3
4
4
Each month's total comprises the sum of three months' worth of ratings.
LYEL Financial Forecast
LYEL Stock Forecast FAQ
What is LYEL’s average 12-month price target, according to analysts?
Based on analyst ratings, Lyell Immunopharma’s 12-month average price target is 28.50.
What is LYEL’s upside potential, based on the analysts’ average price target?
Lyell Immunopharma has 19.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is LYEL a Buy, Sell or Hold?
Lyell Immunopharma has a consensus rating of Hold which is based on 1 buy ratings, 0 hold ratings and 1 sell ratings.
What is Lyell Immunopharma’s price target?
The average price target for Lyell Immunopharma is 28.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $45.00 ,the lowest forecast is $12.00. The average price target represents 19.90% Increase from the current price of $23.77.
The highest analyst price target is $45.00 ,the lowest forecast is $12.00. The average price target represents 19.90% Increase from the current price of $23.77.
What do analysts say about Lyell Immunopharma?
Lyell Immunopharma’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of LYEL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.